Open AccessImmunogenicity and safety of a heterologous prime-boost COVID-19 vaccine schedule: ChAdOx1 vaccine Covishield followed by BBV152 Covaxin
Author(s) -
Rajni Kant,
Gaurav Raj Dwivedi,
Kamran Zaman,
Rima R. Sahay,
Gajanan Sapkal,
Himanshu Kaushal,
Dimpal A Nyayanit,
Pragya D. Yadav,
Gururaj Deshpande,
Rajeev Singh,
Sandeep Chaowdhary,
Nivedita Gupta,
Sanjay Kumar,
Priya Abraham,
Samiran Panda,
Balram Bhargava
Publication year - 2021
Publication title -
journal of travel medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.985
H-Index - 59
eISSN - 1708-8305
pISSN - 1195-1982
DOI - 10.1093/jtm/taab166
Subject(s) - heterologous , immunogenicity , medicine , vaccination , virology , immunology , immunization , adverse effect , regimen , antibody , biology , gene , biochemistry